Empaglibet® (EMPAGLIFLOZIN)

Assess volume status and correct volume depletion before initiating. Recommended dose is 10 mg once daily in the morning, taken with or without food. For additional glycemic control, d...

Trixibet® (Empagliflozin,Linagliptin,Metformin)

Assess renal function before initiating and as clinically indicated. Individualize the starting dose of Trixibet® ER based on the patient’s current regimen and renal function. Initiation o...

Lenvata®(Lenvatinib)

Lenvatinib is a kinase inhibitor that is indicated: • For the treatment of patients with locally recurrent or metastatic,  progressive, radioactive iodine-refractory differentiated thyroi...

Sipomid® (Siponimod)

Assessments are required prior to initiating Sipomid®. Titration is required for treatment initiation. The recommended maintenance dosage is 2 mg. The recommended maintenance ...

Faxibet plus® ER (Dapagliflozin/Metformin)

Individualize the starting dose based on the patient’s current treatment. Assess renal function before initiating and periodically thereafter. To improve glycemic control, for pa...

Teriflunomide

The recommended dose of Teriflunomide is 7 mg or 14 mg orally once daily. Teriflunomide can be taken with or without food.

Faxibet® (Dapagliflozin)

Faxibet® (Dapagliflozin)

Dapagliflozin is a Sodium-glucose cotransporter 2 (SGLT2) inhibitor. Dapagliflozin reduces reabsorption of filtered glucose and increases urinary glucose excretion. Dapagliflozin also reduces sodium r...

Rizolung® (Crizotinib)

•Metastatic NSCLC: The recommended dosage is 250 mg orally twice daily. • Systemic ALCL: The recommended dosage is 280 mg/m2 orally twice daily based on body surface area. Unresectab...

Encastry® (enzalutamide)

160 mg (four 40 mg capsules) Enzalutamide administered orally once daily. Enzalutamide can be taken with or without food. Swallow capsules whole, do not chew, dissolve, or open the capsules. ...

TOFAXEL® (Tofacitinib)

Administration Instructions Changes between Tofaxel® and Tofaxel® ER should be made by the healthcare provider. Do not initiate Tofaxel®/ Tofaxel® ER if absolute lymphocyte...

Simerta® (Osimertinib)

Adjuvant treatment of early stage NSCLC: 80 mg orally once daily, with or without food, until disease recurrence, or unacceptable toxicity, or for up to 3 years. Metastatic NSCL...